학술논문

A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22
Document Type
Article
Source
In: SpringerPlus. (SpringerPlus, 1 December 2015, 4(1)) 11p.
Subject
Language
English
ISSN
21931801